Edwards Lifesciences (NYSE: EW) files Form 144 to sell 26,000 shares

Rhea-AI Filing Summary

Edwards Lifesciences reported a Form 144 covering the proposed sale of 26,000 shares of Common Stock on 03/11/2026. The filing lists Employee Stock Option Exercise - Broker Payment for Cashless Exercise as the transaction method and identifies Charles Schwab & Co. as the broker.

Insights

Insider Transactions Analyst

Routine exercise-and-cashless disposition recorded by broker.

The Form 144 shows an employee stock option exercise where the broker handled a cashless payment and listed 26,000 shares to be sold on 03/11/2026. This pattern commonly reflects option vesting liquidity rather than open-market timing.

Timing and proceeds details are not in the excerpt; subsequent filings or trade reports would state execution outcomes and cash flows.

Securities Counsel

Form 144 documents a proposed resale under SEC resale notice requirements.

The filing lists the broker (Charles Schwab & Co.) and the transaction method verbatim: Broker Payment for Cashless Exercise. The entry on 03/11/2026 is a notice of intent to sell and not a confirmation of completed trades.

Cash‑flow recipients and net proceeds are not disclosed in the excerpt; enforcement- or reporting-related conditions are not shown.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	26000	2207790.00	580800000	03/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/11/2026	Employee Stock Option Exercise - See Remarks	EDWARDS LIFESCIENCES CORPORATION			26000	03/11/2026	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Edwards Lifesciences' (EW) Form 144 report?

It reports a proposed resale of 26,000 common shares via an employee option exercise and broker cashless payment on 03/11/2026. The filing names Charles Schwab & Co. as the broker and lists the transaction method verbatim.

Does the Form 144 confirm the shares were sold for EW?

No. Form 144 is a notice of intent to sell; it does not confirm completion. The excerpt lists the offering method and broker but does not provide execution, proceeds, or settlement details; separate trade reports would confirm sale completion.

What does 'Broker Payment for Cashless Exercise' mean on the Form 144?

It indicates the option exercise used broker-assisted share withholding or sale to cover exercise costs. The filing verbatim states Employee Stock Option Exercise - Broker Payment for Cashless Exercise, showing the method rather than net proceeds or sale execution.

Who is the broker listed on the EW Form 144 and why does it matter?

The broker is Charles Schwab & Co.. Listing the broker identifies the intermediary expected to handle the cashless exercise and any resale; the filing does not state whether trades were executed or the amounts received by any party.